Cite
APA Citation
Pathan, M., Akter, N., Selim, S., Saifuddin, M., Qureshi, N., Hasan, A., Hannan, M., Ahmed, M., Mustari, M., & Chakraborty, A. (n.d.). iDF2022-0559 Efficacy and safety of empagliflozin as an add on to metformin and DPP4 inhibitor in T2DM patients, fasting during Ramadan. Diabetes research and clinical practice, 197, . http://access.bl.uk/ark:/81055/vdc_100180909609.0x00004a